LABT
Lakewood-Amedex Biotherapeutics Inc. Common Stock
NASDAQ: LABT · HEALTHCARE · BIOTECHNOLOGY
$2.95
-4.60% today
Updated 2026-06-02
Market cap
$6.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.26
Dividend yield
—
52W range
$1 – $10
Volume
2.5M
Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item |
|---|
| Operating cash flow |
| Capital expenditures |
| Depreciation |
| Stock-based comp |
| Free cash flow |
| Investing cash flow |
| Financing cash flow |
| Dividends paid |
| Share repurchases |
| Debt repayment |
| Net change in cash |